XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING ACTIVITIES:    
Net income (loss) $ (42,190) $ 24,310
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Share-based compensation expense 9,538 10,428
Depreciation and amortization expense, including amortization of deferred financing costs 58,462 54,637
Deferred rent (7,051) (8,733)
Income from unconsolidated real estate ventures, net (975) (433)
Amortization of market lease intangibles, net 58 (253)
Amortization of lease incentives 2,696 741
Impairment loss 17,211  
Gain on the sale of real estate, net (197) (40,700)
Loss (income) on operating lease and other receivables 311 (1,215)
Income from investments, net (20) (1,798)
Return on capital from unconsolidated real estate ventures 1,179 3,861
Other non-cash items 365 3,032
Changes in operating assets and liabilities:    
Tenant and other receivables 3,710 11,624
Other assets, net 464 1,420
Accounts payable and accrued expenses (6,015) (16,069)
Other liabilities, net (503) 1,780
Net cash provided by operating activities 37,043 42,632
INVESTING ACTIVITIES:    
Development costs, construction in progress and real estate additions (47,982) (78,332)
Acquisition of real estate   (450)
Proceeds from the sale of real estate 12,410 68,998
Proceeds from derivative financial instruments 1,465  
Distributions of capital from unconsolidated real estate ventures and other investments 160,250  
Investments in unconsolidated real estate ventures and other investments (2,541) (16,889)
Net cash provided by (used in) investing activities 123,602 (26,673)
FINANCING ACTIVITIES:    
Borrowings under mortgage loans 31,600 223,303
Borrowings under revolving credit facility 30,000  
Repayments of mortgage loans (786) (133,860)
Repayments of revolving credit facility (92,000)  
Payments on derivative financial instruments (1,465)  
Debt issuance and modification costs (10) (7,206)
Redemption of partner's noncontrolling interest   (647)
Proceeds from common shares issued pursuant to ESPP 292  
Common shares repurchased (49,444) (20,098)
Dividends paid to common shareholders (16,066) (25,664)
Distributions to redeemable noncontrolling interests (2,931) (3,968)
Distributions to noncontrolling interests (10)  
Net cash (used in) provided by financing activities (100,820) 31,860
Net decrease increase in cash and cash equivalents, and restricted cash 59,825 47,819
Cash and cash equivalents, and restricted cash, beginning of period 200,441 274,073
Cash and cash equivalents, and restricted cash, end of period 260,266 321,892
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION:    
Cash paid for interest (net of capitalized interest of $3,008 and $5,175 in 2024 and 2023) 25,623 22,705
Accrued capital expenditures included in accounts payable and accrued expenses 77,358 72,375
Write-off of fully depreciated assets 10,574 192
Redemption of OP Units for common shares 7,875 13,782
Recognition of operating lease right-of-use asset   61,443
Recognition of liabilities related to operating lease right-of-use asset   61,443
Cash paid for amounts included in the measurement of lease liabilities for operating leases $ 1,616 $ 398